Return to homepagePandemic Pact

To develop human ACE2 transgenic mice in strains that express all classes of human FcγRs to study the mechanisms of antibody-mediated protection against Covid-19 infection.

  • Funded by Emergent Ventures Fast Grants
  • Total publications:0 publications

Grant number: unknown

Grant search

Key facts

  • Disease

    COVID-19

  • Funder

    Emergent Ventures Fast Grants

  • Principal Investigator

    Dr. Jeffrey Ravetch

  • Research Location

    United States of America

  • Lead Research Institution

    The Rockefeller University

  • Research Priority Alignment

    N/A

  • Research Category

    Pathogen: natural history, transmission and diagnostics

  • Research Subcategory

    Immunity

  • Special Interest Tags

    N/A

  • Study Type

    Non-Clinical

  • Clinical Trial Details

    N/A

  • Broad Policy Alignment

    Pending

  • Age Group

    Not Applicable

  • Vulnerable Population

    Not applicable

  • Occupations of Interest

    Not applicable

Abstract